science1 publisher
Two years off GLP-1s wiped out most of the heart benefit in a 333,000-veteran cohort
Veterans with type 2 diabetes who came off semaglutide or tirzepatide lost most of the cardiovascular benefit within two years, and the benefit only appeared in patients who had stayed on the drug past 18 months.
Publishers:sciencedaily.com
Reality
- Evidence62
- Adoption72
- Hype gap+20
- Incentives58
- Confidence52